A 10-year study has discovered a new treatment approach that doubles the survival chances of men with locally advanced prostate cancer. The University of Newcastle study shows combining radiotherapy with six months of hormone therapy significantly reduces the death rate of prostate cancer patients. Researchers found the rate of prostate cancer death for men receiving radiotherapy with six months’ hormone therapy was reduced to 11 per cent, compared to 22 per cent for men receiving radiotherapy alone.
Read more at University of Newcastle
Academic rigor, journalistic flair
Want to write?
Write an article and join a growing community of more than 182,500 academics and researchers from 4,943 institutions.